The impact of respiratory comorbidity on overall survival in patients with multiple myeloma

Multiple myeloma (MM) and respiratory diseases are considered as independent risk factors of infectious complications. Treatment outcomes of patients with MM and respiratory comorbidity are not defined yet. The study included 156 patients with newly diagnosed MM. Respiratory comorbidity was considered clinically significant only in cases requiring treatment or outpatient monitoring. Overall survival was significantly lower in group of patients with respiratory comorbidity compared to group without chronic respiratory diseases (43 vs 86 months, p